Agenus

Agenus to Present Phase II Data on BOT+BAL with Agent-797 in PD-1–Refractory Gastroesophageal Cancer at AACR 2026

Agenus to Present Phase II Data on Novel BOT+BAL and agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 Agenus a biotechnology company focused on advancing immuno-oncology therapies, has announced that new clinical data from an investigator-initiated Phase II…

Read MoreAgenus to Present Phase II Data on BOT+BAL with Agent-797 in PD-1–Refractory Gastroesophageal Cancer at AACR 2026
GenSight

GenSight Biologics Reports Full-Year 2025 Financial Results in Line with Expectations

GenSight Biologics Confirms Full-Year 2025 Financial Results in Line with Prior Estimates GenSight Biologics a clinical-stage biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has confirmed that its final consolidated financial results…

Read MoreGenSight Biologics Reports Full-Year 2025 Financial Results in Line with Expectations
Allevion

Allevion Medical Secures 510(k) Clearance for Vantage Disposable Kit, Advancing Spinal Decompression

Allevion Medical Secures FDA Clearance for Vantage™ Disposable System for Spinal Decompression Allevion Medical has announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its innovative Vantage™ system, a fully disposable and sterile solution designed…

Read MoreAllevion Medical Secures 510(k) Clearance for Vantage Disposable Kit, Advancing Spinal Decompression
VDYNE

VDYNE Secures FDA Approval to Launch TRIVITA1 Pivotal IDE Trial for Its Transcatheter Tricuspid Valve Replacement System

VDYNE Secures FDA IDE Approval to Advance Pivotal TRIVITA1 Trial for Transcatheter Tricuspid Valve Replacement System VDYNE, Inc., a privately held medical device innovator focused on next-generation transcatheter valve therapies, has achieved a major regulatory milestone with the approval of…

Read MoreVDYNE Secures FDA Approval to Launch TRIVITA1 Pivotal IDE Trial for Its Transcatheter Tricuspid Valve Replacement System
SCP

SCP Health Broadens Performance Edge Model to Enhance Hospital-Based Care

SCP Health Expands Performance Edge Model to Strengthen Hospital-Based Care Hospitals across the United States are navigating an increasingly complex healthcare environment marked by workforce shortages, financial pressures, and rising administrative demands. In response to these challenges, SCP Health, a…

Read MoreSCP Health Broadens Performance Edge Model to Enhance Hospital-Based Care
RefleXion

RefleXion Gains Expanded Medicare Coverage for SCINTIX Cancer Therapy

RefleXion Expands Medicare Reimbursement for SCINTIX Therapy Across Majority of U.S. Regions RefleXion Medical has announced a significant advancement in expanding access to its innovative SCINTIX® autonomous radiotherapy, as another Medicare Administrative Contractor (MAC), Noridian Healthcare Solutions, LLC, has approved…

Read MoreRefleXion Gains Expanded Medicare Coverage for SCINTIX Cancer Therapy